AbbVie (ABBV) Stock Price, Quote, News & History | Benzinga

AbbVie Inc (ABBV) Stock Price, Quote, News & History

ABBVNYSE

Trade with Public

Trade with Public

$246.04

2.170.89%

At close: Aug 7, 5:00 PM EST

$245.89

-0.15-0.06%

After Hours: 6:53 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$243.62

Close

$246.04

Volume / Avg.

4.93M / 6.82M

Day Range

$241.95 - $246.76

52 Wk Range

190.75 - 267.47

Market Cap

$434.92B

P/E Ratio

68.89

Dividend Yield

2.84%

Exchange

NYSE

RSI

47

Short Interest

1.42%

Days to Cover

3.45

Recent AbbVie Inc. News

Kathy Hochul Slams Trump Over Medicare Cut, Says 1.3 Million New Yorkers Will Pay More for Prescriptions: 'A New Assault on Seniors...'

Kathy Hochul says Trump's Medicare subsidy decision will raise prescription drug costs for 1.3 million New Yorkers.

Tanya Rawat

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

AstraZeneca and Bristol Myers reportedly discuss a $400 billion merger as analyst assesses valuation, patent risks and regulatory hurdles.

Vandana Singh

Stock Market Today: Amazon Jumps 15%, Apple Wipes Out $475 Billion

Amazon surges 15% on an AWS blowout while Apple sheds nearly $475 billion in value. Yields sit at cycle highs.

Piero Cingari

Moleculin Biotech Stock Is Sinking Friday: What's Going On?

Moleculin Biotech updates MIRACLE trial for AML and prices a $9.3M offering at $0.75, driving MBRX shares down 63%. Read full data.

Vandana Singh

AbbVie Stock Falls as Guidance Cut Overshadows Strong Q2 Earnings Beat

AbbVie Inc. (NYSE: ABBV) shares are retreating Friday after trimming full-year adjusted EPS guidance below analyst targets.

Evette Mitkov

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

19.51B

Investing Cash Flow (TTM)

-6.50B

Financing Cash Flow (TTM)

-12.89B

Free Cash Flow (TTM)

18.21B

Capital Expenditure (TTM)

-1.30B

Net Change in Cash (TTM)

118.00M

Analyst Trends and Forecast

4

May

2

Jun

9

2

Jul

3

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$499.03B

PE Ratio (TTM)

68.89

PE Ratio (FWD)

17.36

PEG Ratio (TTM)

0.40

PS Ratio (TTM)

6.72

PB Ratio (TTM)

-

Earnings Yield % (TTM)

1.45%

Earnings Yield % (FWD)

5.76%

EV / EBITDA (TTM)

25.42

Price / EBITDA (TTM)

22.20

Price / Free Cash Flow (TTM)

23.75

Book Value / Share

-$3.36

Company Debt

Total Debt

$70.82B

LT Debt

$62.48B

LT Debt Issuance (TTM)

$7.99B

LT Debt Repayment (TTM)

-$2.02B

Total Cash

$6.57B

Debt to Equity

-

Issuance of Debt (TTM)

$5.97B

Repayment of Debt (TTM)

-$7.31B

Key Statistics

Open

$243.62

Close

$246.04

Volume / Avg.

4.93M / 6.82M

Day Range

$241.95 - $246.76

52 Wk Range

190.75 - 267.47

Market Cap

$434.92B

P/E Ratio

68.89

Dividend Yield

2.84%

Exchange

NYSE

RSI

47

Short Interest

1.42%

Days to Cover

3.45

About

Sector

Health Care

Industry

Biotechnology

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several ne...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy AbbVie (ABBV) stock?

A

You can purchase shares of AbbVie (NYSE:ABBV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are AbbVie (ABBV) competitors?

A

Other companies in AbbVie’s space includes: Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and argenx SE (NASDAQ:ARGX).

Q

What is the forecast, or price target, for AbbVie (ABBV) stock?

A

AbbVie has a consensus price target of $257.12.

Q

What is the current price for AbbVie (ABBV)?

A

The stock price for AbbVie (NYSE: ABBV) is $245.89 last updated August 7, 2026 at 6:53 PM EDT.

Q

Does AbbVie (ABBV) pay a dividend?

A

There are no upcoming dividends for AbbVie.

Q

When is AbbVie (NYSE:ABBV) reporting earnings?

A

AbbVie does not have any upcoming earnings scheduled.

Q

Is AbbVie (ABBV) going to split?

A

There is no upcoming split for AbbVie.

Q

What sector and industry does AbbVie (ABBV) operate in?

A

AbbVie is in the Health Care sector and Biotechnology industry. They are listed on the NYSE.